ArcherDX is now Invitae, bringing the future of precision oncology to cancer care. The transaction was completed in October 2020. Learn more here. 

Precision oncology
in your lab

ArcherDX is now Invitae. The combination was completed in October 2020 to bring comprehensive cancer genetics and precision oncology to patients worldwide.

The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.

We aim to address barriers to bringing precision oncology to patients, anywhere
We are global
We provide expansive
access
menu home-icon-silhouette remove-button twitter linkedin-1 facebook-circular-logo right